Search by Drug Name or NDC

    NDC 63868-0019-12 Quality Choice Maximum Strength Antacid 800; 80; 800 mg/10mL; mg/10mL; mg/10mL Details

    Quality Choice Maximum Strength Antacid 800; 80; 800 mg/10mL; mg/10mL; mg/10mL

    Quality Choice Maximum Strength Antacid is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Chain Drug Marketing Association Inc.. The primary component is ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE.

    Product Information

    NDC 63868-0019
    Product ID 63868-019_a12b9032-7b40-4868-8fc1-563e0c050e1f
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Quality Choice Maximum Strength Antacid
    Proprietary Name Suffix n/a
    Non-Proprietary Name aluminum hydroxide, magnesium hydroxide, simethicone
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 800; 80; 800
    Active Ingredient Units mg/10mL; mg/10mL; mg/10mL
    Substance Name ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE
    Labeler Name Chain Drug Marketing Association Inc.
    Pharmaceutical Class Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part331
    Listing Certified Through 2024-12-31

    Package

    NDC 63868-0019-12 (63868001912)

    NDC Package Code 63868-019-12
    Billing NDC 63868001912
    Package 355 mL in 1 BOTTLE (63868-019-12)
    Marketing Start Date 2022-08-02
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL a12b9032-7b40-4868-8fc1-563e0c050e1f Details

    Revised: 8/2022